Acute
liver injury is a critical syndrome ascribed to prevalent
death of hepatocytes and imperatively requires liver transplantation.
Such a methodology is certainly hampered due to the deficit of healthy
donors. In this regard, stem cell-based regenerative therapies are
attractive in repairing injured tissues and organs for medical applications.
However, it is crucial to understand the migration, engraftment, and
regeneration capabilities of transplanted stem cells in the living
animal models. For the first time, we demonstrate rapid labeling of
umbilical cord-derived mesenchymal stem cells (MSCs) with near-infrared
(NIR)-fluorescent CuInS2–ZnS nanocrystals (CIZS-NCs)
to develop innovative nanobioconjugates (MSCs-CIZS-NBCs) that exhibit
98% labeling efficiency. Before nanobioconjugate synthesis, the pristine
CIZS-NCs were prepared via a two-step, hot-injection, rapid and low-cost
domestic-microwave-refluxing (MW-R) method within 6 min. The as-synthesized
CIZS-NCs display high photoluminescence quantum yield (∼88%)
and long-lived lifetime (23.4 μs). In contrast to unlabeled
MSCs, the MSCs-CIZS nanobioconjugates show excellent biocompatibility
without affecting the stemness, as confirmed by cell viability, immunophenotyping
(CD44+, CD105+, CD90+), multi-lineage-specific
gene expressions, and differentiation into adipocytes, osteocytes,
and chondrocytes. The in vivo fluorescence tracking analyses revealed
that the MSCs-CIZS-NBCs after tail-vein injection were initially trapped
in the lungs and gradually engrafted in the injured liver within 2
h. The regeneration potential of MSCs-CIZS-NBCs was confirmed via
renewal of the portal tract composed of portal veins, bile ducts,
and hepatic arteries around the hepatocytes. Consequently, no apparent
inflammations, necrosis, or apoptosis was observed in the acetaminophen
(APAP)-induced liver-injured BALB/c mice model over 3 days after transplantation,
as corroborated using laser-scanning confocal microscopy and histopathological
and hematological analyses. Hence, our innovative NIR-fluorescent
MSCs-CIZS-NBCs offer an off-the-self technology for noninvasive tracking
of transplanted MSCs in an acute-liver-injured animal model for future image-guided cell-therapies.